Literature DB >> 2562840

The structure of tyrosine aminotransferase. Evidence for domains involved in catalysis and enzyme turnover.

J L Hargrove1, H A Scoble, W R Mathews, B R Baumstark, K Biemann.   

Abstract

The primary structure of tyrosine aminotransferase, as deduced from the nucleotide sequence of complementary DNA, was confirmed by fast atom bombardment mass spectrometry of tryptic peptides derived from the purified protein. Limited digestion of the native enzyme with trypsin released an acetylated, amino-terminal peptide; the new amino terminus in the modified enzyme was Val65. Endogenous proteases generated a chromatographically separable form of tyrosine aminotransferase that began at Lys35. Neither trypsin nor the other proteases altered the catalytic activity of tyrosine aminotransferase. Reduction of the holoenzyme with sodium borohydride yielded a major tryptic peptide containing phosphopyridoxamine bound to lysine 280, which probably functions in transamination. The carboxyl terminus of tyrosine aminotransferase contains features that typify proteins with short half-lives; it includes two negatively charged, hydrophilic segments that are enriched for glutamyl residues and are similar to a PEST region in ornithine decarboxylase (Rogers, S., Wells, R., and Rechsteiner, M. (1986) Science 234, 364-368). Tyrosine aminotransferase belongs to a superfamily of enzymes which includes aspartate aminotransferase and can be aligned so that many invariant, functional residues coincide. Like the isoenzymes of aspartate aminotransferase, tyrosine aminotransferase may contain two domains, with a central, catalytic core, and a small domain made up of both amino- and carboxyl-terminal components. We speculate that the exposed small domain may confer the unusually rapid degradative rate that characterizes this enzyme.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562840

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Ubiquitin-mediated degradation of tyrosine aminotransferase (TAT) in vitro and in vivo.

Authors:  A Ciechanover; J L Hargrove; S Gross-Mesilaty
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

Review 2.  Ethylene biosynthesis and action: a case of conservation.

Authors:  T I Zarembinski; A Theologis
Journal:  Plant Mol Biol       Date:  1994-12       Impact factor: 4.076

3.  Purification and partial structural and kinetic characterization of tyrosine aminotransferase from epimastigotes of Trypanosoma cruzi.

Authors:  M Montemartini; J A Santomé; J J Cazzulo; C Nowicki
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

4.  Cloning and characterization of a coronatine-regulated tyrosine aminotransferase from Arabidopsis.

Authors:  A Lopukhina; M Dettenberg; E W Weiler; H Holländer-Czytko
Journal:  Plant Physiol       Date:  2001-08       Impact factor: 8.340

5.  Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II.

Authors:  E Natt; K Kida; M Odievre; M Di Rocco; G Scherer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

6.  Isolation and characterization of the human tyrosine aminotransferase gene.

Authors:  R Rettenmeier; E Natt; H Zentgraf; G Scherer
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

7.  Destabilization of tyrosine aminotransferase by amino acids.

Authors:  J L Hargrove; C Liu
Journal:  Amino Acids       Date:  1994-10       Impact factor: 3.520

8.  Structure of tyrosine aminotransferase from Leishmania infantum.

Authors:  M A Moreno; A Abramov; J Abendroth; A Alonso; S Zhang; P J Alcolea; T Edwards; D Lorimer; P J Myler; V Larraga
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-04-25       Impact factor: 1.056

9.  Metabolic Engineering of Saccharomyces cerevisiae for Rosmarinic Acid Production.

Authors:  Mahsa Babaei; Gheorghe M Borja Zamfir; Xiao Chen; Hanne Bjerre Christensen; Mette Kristensen; Jens Nielsen; Irina Borodina
Journal:  ACS Synth Biol       Date:  2020-07-27       Impact factor: 5.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.